Just a reminder to everyone that PIQ previously advised (in their November 24 Investor Presentation) that they are also expecting the updated results from on-going trials of their Esophageal cancer and OxiDx diagnostic test as well. Previous test results have shown a high degree of success for these.
Success would mean that PIQ will have 4 first in class diagnostic tests that could positively benefit many millions world wide and generate substantial cash flow for PIQ (and a possible take-over bat some point).
Why some shareholders feel the need to sell now for what will likely be relatively minor gains is beyond me.
Just a reminder to everyone that PIQ previously advised (in...
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.010(2.67%) |
Mkt cap ! $59.68M | |||
| Open | High | Low | Value | Volume |
| 37.5¢ | 37.5¢ | 36.0¢ | $41.74K | 113.7K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 14946 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 95239 | 2 |
View Market Depth
| Last trade - 15.57pm 18/06/2025 (20 minute delay) ? |
| PIQ (ASX) Chart |